These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1768436)

  • 1. Growth inhibitory effects of transforming growth factor-beta 1 in vivo.
    Migdalska A; Molineux G; Demuynck H; Evans GS; Ruscetti F; Dexter TM
    Growth Factors; 1991; 4(3):239-45. PubMed ID: 1768436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fraction unresponsive to growth inhibition by TGF-beta among the high-proliferative potential progenitor cells in bone marrow of p53-deficient mice.
    Sasaki H; Matsuda M; Lu Y; Ikuta K; Matsuyama S; Hirabayashi Y; Mitsui H; Matsumura T; Muramatsu M; Tsukada T; Aizawa S; Inoue T
    Leukemia; 1997 Feb; 11(2):239-44. PubMed ID: 9009087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant transforming growth factor beta 1 and beta 2 protect mice from acutely lethal doses of 5-fluorouracil and doxorubicin.
    Grzegorzewski K; Ruscetti FW; Usui N; Damia G; Longo DL; Carlino JA; Keller JR; Wiltrout RH
    J Exp Med; 1994 Sep; 180(3):1047-57. PubMed ID: 8064224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood.
    Strife A; Lambek C; Perez A; Darzynkiewicz Z; Skierski J; Gulati S; Haley JD; ten Dijke P; Iwata KK; Clarkson BD
    Cancer Res; 1991 Sep; 51(18):4828-36. PubMed ID: 1893375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of primitive hemopoietic colony-forming cells by an extract from normal marrow: comparison with transforming growth factor-beta.
    Hampson J; Redmond S; Lord BI; Slocombe P; O'Farrell AM; Heyworth CM; Dexter TM
    Exp Hematol; 1991 May; 19(4):245-9. PubMed ID: 2055288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of hematopoietic colony-forming cells. Normal bone marrow extract versus transforming growth factor-beta 1.
    Hampson J; Lord BI; Redmond S; Slocombe P
    Ann N Y Acad Sci; 1991; 628():44-51. PubMed ID: 2069320
    [No Abstract]   [Full Text] [Related]  

  • 7. Lisofylline suppresses ex vivo release by murine spleen cells of hematopoietic inhibitors induced by cancer chemotherapeutic agents.
    de Vries P; Singer JW
    Exp Hematol; 2000 Aug; 28(8):916-23. PubMed ID: 10989192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor beta 1 directly and reversibly inhibits the initial cell divisions of long-term repopulating hematopoietic stem cells.
    Sitnicka E; Ruscetti FW; Priestley GV; Wolf NS; Bartelmez SH
    Blood; 1996 Jul; 88(1):82-8. PubMed ID: 8704205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autocrine transforming growth factor beta 1 blocks colony formation and progenitor cell generation by hemopoietic stem cells stimulated with steel factor.
    Ploemacher RE; van Soest PL; Boudewijn A
    Stem Cells; 1993 Jul; 11(4):336-47. PubMed ID: 7691312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of granulopoiesis by transforming growth factor beta: synergy with granulocyte/macrophage-colony-stimulating factor.
    Keller JR; Jacobsen SE; Sill KT; Ellingsworth LR; Ruscetti FW
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7190-4. PubMed ID: 1831268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo and in vitro effects of TGF-beta 1 on normal and neoplastic haemopoiesis.
    Ruscetti FW; Dubois C; Falk LA; Jacobsen SE; Sing G; Longo DL; Wiltrout RH; Keller JR
    Ciba Found Symp; 1991; 157():212-27; discussion 227-31. PubMed ID: 1649034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrasting effects of rh-MIP-1 alpha and TGF-beta 1 on chronic myeloid leukemia progenitors in vitro.
    Holyoake TL; Freshney MG; Sproul AM; Richmond LJ; Alcorn MJ; Steward WP; Fitzsimons E; Dunlop DJ; Franklin IM; Pragnell IB
    Stem Cells; 1993 Oct; 11 Suppl 3():122-8. PubMed ID: 8298472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor beta: is it a downregulator of stem cell inhibition by macrophage inflammatory protein 1 alpha?
    Maltman J; Pragnell IB; Graham GJ
    J Exp Med; 1993 Sep; 178(3):925-32. PubMed ID: 8394405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the inhibitory effect of AcSDKP, TNF-alpha, TGF-beta, and MIP-1 alpha on marrow-purified CD34+ progenitors.
    Bonnet D; Lemoine FM; Najman A; Guigon M
    Exp Hematol; 1995 Jun; 23(6):551-6. PubMed ID: 7539383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combined effects of all-trans retinoic acid and TGF-beta on the initial proliferation of normal human bone marrow progenitor cells.
    Lardon F; Snoeck HW; Haenen L; Lenjou M; Nijs G; Weekx SF; Van Ranst PC; Berneman ZN; Van Bockstaele DR
    Leukemia; 1996 Dec; 10(12):1937-43. PubMed ID: 8946934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation.
    Murohashi I; Endho K; Nishida S; Yoshida S; Jinnai I; Bessho M; Hirashima K
    Exp Hematol; 1995 Aug; 23(9):970-7. PubMed ID: 7543418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.
    Mayani H; Little MT; Dragowska W; Thornbury G; Lansdorp PM
    Exp Hematol; 1995 May; 23(5):422-7. PubMed ID: 7536684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Goralatide (AcSDKP) selectively protects murine hematopoietic progenitors and stem cells against hyperthermic damage.
    Wierenga PK; Konings AW
    Exp Hematol; 1996 Feb; 24(2):246-52. PubMed ID: 8641348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential proliferative effects of transforming growth factor-beta on human hematopoietic progenitor cells.
    Ottmann OG; Pelus LM
    J Immunol; 1988 Apr; 140(8):2661-5. PubMed ID: 3258618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased granulopoiesis after sequential administration of transforming growth factor-beta 1 and granulocyte-macrophage colony-stimulating factor.
    Hestdal K; Jacobsen SE; Ruscetti FW; Longo DL; Boone TC; Keller JR
    Exp Hematol; 1993 Jun; 21(6):799-805. PubMed ID: 8500577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.